Anthony G. Viscogliosi, Founder and Executive Chairman of Small Bone
Innovations, Inc., Returning to Merchant Banking
NEW YORK -- January 31, 2013
Anthony G. Viscogliosi, the Founder and Executive Chairman of Small Bone
Innovations, Inc., (SBi), announced that he will relinquish his executive
management duties at SBi after eight years as CEO and, for the past year, as
Executive Chairman. He will continue as a member of SBi’s Board of Directors.
In taking the step to resume fulltime activities as a principal of Viscogliosi
Brothers, LLC (VB), Mr. Viscogliosi emphasized the need to seize growing
opportunities for VB in its merchant banking, venture capital and private
equity business dedicated to the neuro-musculoskeletal orthopedics industry.
“Today, SBi is the only pure-play small bone and joint (SBJ) arthroplasty and
reconstruction company - with critical mass in revenues, products, balance
sheet and global distribution. The company is profitable and growing rapidly,
having achieved leadership in the $3 billion SBJ space – the fastest growing
segment of the orthopedic device market. VB identified and redefined SBJ
treatment as a growth opportunity nearly a decade ago. Having actualized that
potential it is time to focus on replicating SBi’s success with VB’s other
investments in the neuro-musculoskeletal orthopedics industry,” Mr.
VB formed SBi in 2005 by rolling up a few small companies with established
products to complement a vision of global leadership in SBJ arthroplasty and
joint-related trauma reconstruction. This vision was realized through the
acquisition of the STAR™ total ankle that received Pre-Market Approval (PMA)
from the US Food and Drug Administration in 2009 and has become the #1 selling
ankle joint arthroplasty system for treating late-stage ankle arthritis.
As an initial step in this management transition, SBi recruited Michael P.
Simpson as President and CEO in February 2012, with Mr. Viscogliosi moving up
to Executive Chairman.
"Anthony has been instrumental in creating the SBJ franchise through his
vision and tenacity in bringing SBi to the forefront. Our job now is to ensure
the company and its products become synonymous with the gold standards for
preserving the small bones and joints," Mr. Simpson noted.
Previously, Mr. Viscogliosi co-founded and acted as Chairman and CEO of Spine
Solutions, Inc. that was sold in 2003 to what is now the DePuy Synthes
Companies of Johnson & Johnson for $350 million. He was also a co-founder and
board member of the company that subsequently became Ascent Healthcare
Solutions, Inc. and was sold to Stryker Corporation for $525 million in 2009.
Mr. Viscogliosi has held board level and executive positions in approximately
40 orthopedics-focused companies. His more than 20-year career in investment
banking includes stints at what is now Oppenheimer & Co. Inc., Rodman &
Renshaw LLC, and Stifel Nicolaus & Co. Inc. During this period he became
uniquely recognized for defining orthopedic and spine devices as a distinct
branch of the health care industry. During the same period he served as an
officer in the US Navy Reserve and helped create seven not-for-profit medical
About Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2005 by Viscogliosi
Brothers, LLC (VB), the New York-based merchant banking firm that specializes
in the neuro-musculoskeletal/orthopedics sector. SBi was the first company to
focus purely on small bones and joints by integrating established companies
and professionals in the field. It offers a broad, clinically proven portfolio
of products and technologies to treat trauma and diseases in the small bones
and joints. SBi has facilities in New York, NY, Morrisville, PA, Péronnas,
France, Donaueschingen, Germany, and Kuala Lumpur, Malaysia and has sold its
products in 41 countries.
For a notice on Forward Looking Statements and more information about SBi,
please visit: www.totalsmallbone.com/us/press.php4
Small Bone Innovations, Inc.
Varun Gandhi, 212-583-0370 ext. 2129
Press spacebar to pause and continue. Press esc to stop.